BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2516078)

  • 1. Indium-111 oxine labeled erythrocytes: cellular distribution and efflux kinetics of the label.
    Kurantsin-Mills J; Jacobs HM; Siegel R; Cassidy MM; Lessin LS
    Int J Rad Appl Instrum B; 1989; 16(8):821-7. PubMed ID: 2516078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro and in vivo studies using 111 indium oxine, 111 indium oxine sulfate and 99m Tc oxine in erythrocyte labeling].
    Reiter S; Angelberger P; Kolbe H; Sinzinger H
    Wien Klin Wochenschr; 1984 Feb; 96(3):120-3. PubMed ID: 6426172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of leukocytes labeled with indium-111-2-mercaptopyridine-N-oxide and indium-111 oxine for abscess detection.
    Intenzo CM; Desai AG; Thakur ML; Park CH
    J Nucl Med; 1987 Apr; 28(4):438-41. PubMed ID: 3106593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular survival of leukemic cells labeled with indium-111-oxine.
    Uchida T; Takagi Y; Matsuda S; Ishibashi T; Kimura H; Kariyone S
    Ann Nucl Med; 1987 Sep; 1(1):33-8. PubMed ID: 3152773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labeling autologous leukocytes with indium-111 oxine.
    Beightol RW; Baker WJ
    Am J Hosp Pharm; 1980 Jun; 37(6):847-50. PubMed ID: 6772025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Technic of radioactive labeling of autologous human thrombocytes using 111-indium-oxine and 111-indium-oxine-sulfate and their clinical use].
    Jäger E; Kolbe H; Silberbauer K; Sinzinger H; Höfer R
    Wien Klin Wochenschr; 1984 Feb; 96(3):106-12. PubMed ID: 6426171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucocyte and contaminant cell-bound activities resulting from the labelling of leucocytes with 111In-oxine.
    Mountford PJ; Allsopp MJ; Hall FM; Wells CP; Coakley AJ
    Eur J Nucl Med; 1985; 10(7-8):304-7. PubMed ID: 3924618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of contaminant indium-114m/indium-114 to indium-111 oxine blood dosimetry.
    Marcus CS; Stabin MG; Watson EE; Kuperus JH
    J Nucl Med; 1985 Sep; 26(9):1091-3. PubMed ID: 3928839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of indium-oxine labelled red cells in haemolytic anaemias.
    Najean Y; Pommier Y; Deschryver F; Chomienne C
    Eur J Nucl Med; 1986; 12(8):379-80. PubMed ID: 3098565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oxine and tropolone methods for labeling human platelets with indium-111.
    Kotzé HF; Heyns AD; Lötter MG; Pieters H; Roodt JP; Sweetlove MA; Badenhorst PN
    J Nucl Med; 1991 Jan; 32(1):62-6. PubMed ID: 1899112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acetaminophen on the leukocyte-labeling efficiency of indium oxine In 111.
    Augustine SC; Schmelter RF; Nelson KL; Petersen RJ; Qualfe MA
    Am J Hosp Pharm; 1983 Nov; 40(11):1965-7. PubMed ID: 6418003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absent splenic uptake of indium-111-oxine-labeled autologous leukocytes in functional asplenia.
    Hicks RJ; Young W; Shapiro B; Kuhl DE
    J Nucl Med; 1991 Mar; 32(3):524-6. PubMed ID: 1900887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of several indium-111 ligands in labeling blood cells: effect of diethylpyrocarbonate and CO2.
    Goedemans WT; de Jong MM
    J Nucl Med; 1987 Jun; 28(6):1020-6. PubMed ID: 3108467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two methods of labelling autologous platelets with 111In-oxine in five different species.
    Christenson JT; Arvidsson D; Thörne J; Olsson PI; Norgren L; Strand SE
    Eur J Nucl Med; 1983; 8(9):389-92. PubMed ID: 6414817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Labeling of erythrocytes with indium oxinate].
    Franke U; Kleinert P; Penzel E; Endert G; Schumann E
    Radiobiol Radiother (Berl); 1984; 25(3):465-71. PubMed ID: 6433398
    [No Abstract]   [Full Text] [Related]  

  • 16. [Scintigraphy with 111In-labeled leukocytes: simplified procedure for labeling].
    Terada H; Shiire Y; Koizumi K; Aburano T; Tonami N; Hisada K
    Radioisotopes; 1987 Dec; 36(12):645-9. PubMed ID: 3128847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell labeling with indium-111-oxine as a marker of cell attachment to bioprosthetic surfaces.
    Sharefkin JB; Lather C; Smith M; Rich NM
    J Biomed Mater Res; 1983 Mar; 17(2):345-57. PubMed ID: 6221015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of cutaneous leukemia with accumulation of In-111-oxine labeled autologous leukemic cells].
    Takagi Y; Kokubun K; Konno M; Matsuda S; Uchida T; Kariyone S
    Kaku Igaku; 1985 Nov; 22(11):1717-9. PubMed ID: 3938496
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of granulocytes and labelling with indium 111-oxine sulphate.
    Pfeiffer G; Erten J; Deubelbeiss K
    Eur J Nucl Med; 1982; 7(5):195-6. PubMed ID: 7094920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of in-vitro labeling of endothelial cells with indium-111 oxine.
    Carr HM; Smyth JV; Rooney OB; Dodd PD; Sharma H; Walker MG
    Cell Transplant; 1995; 4(3):291-6. PubMed ID: 7640868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.